PCI Biotech Holding ASA (OSL:PCIB)
Norway flag Norway · Delayed Price · Currency is NOK
0.2810
-0.0220 (-7.26%)
Oct 3, 2025, 4:17 PM CET

PCI Biotech Holding ASA Revenue

PCI Biotech Holding ASA had revenue of 1.38M NOK in the half year ending June 30, 2025, with 230.70% growth. This brings the company's revenue in the last twelve months to 4.69M, down -21.85% year-over-year. In the year 2024, PCI Biotech Holding ASA had annual revenue of 6.74M with 125.25% growth.

Revenue (ttm)
4.69M
Revenue Growth
-21.85%
P/S Ratio
2.24
Revenue / Employee
937.60K
Employees
5
Market Cap
10.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.74M3.75M125.25%
Dec 31, 20232.99M-1.76M-37.05%
Dec 31, 20224.75M-1.52M-24.28%
Dec 31, 20216.27M-1.10M-14.86%
Dec 31, 20207.37M-2.02M-21.55%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition